Cardinal Health, Inc.
Moat Score — Cardinal Health, Inc.
Total Moat Score
13 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 2 / 5 | Cardinal Health has an entrenched reputation and deep manufacturer/provider relationships built over decades, along with DEA licensing for controlled substances, but it carries little consumer-facing brand value. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 3 / 5 | Massive transaction volume and negotiated manufacturer rebates give Cardinal Health real purchasing-scale advantages, particularly in generic drug sourcing, though its operating margin remains razor-thin at around 1%. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 1 / 5 | As a distribution intermediary serving large, consolidated retail pharmacy chains and PBMs, Cardinal Health has very limited pricing power and is a price-taker squeezed by powerful customers on one side and manufacturers on the other. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 0 / 5 | Pharmaceutical distribution logistics exhibit no network effect between customers using the wholesaler. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 3 / 5 | Hospitals and pharmacies rely on Cardinal Health's integrated inventory management, data analytics, and just-in-time logistics, making it operationally disruptive and risky to switch primary wholesalers. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 4 / 5 | Cardinal Health, McKesson, and Cencora form an entrenched three-player oligopoly protected by the extreme capital intensity, regulatory complexity (DEA tracking, cold-chain, radioactive materials), and thin-margin economics that make new entry largely uneconomical. |